login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
CATALYST PHARMACEUTICALS INC (CPRX) Stock News
USA
-
Nasdaq
- NASDAQ:CPRX -
US14888U1016
-
Common Stock
23.41
USD
-0.02 (-0.09%)
Last: 11/28/2025, 8:21:28 PM
23.5049
USD
+0.09 (+0.41%)
After Hours:
11/28/2025, 8:21:28 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CPRX Latest News, Press Relases and Analysis
All
Press Releases
21 hours ago - By: Chartmill
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Represents an Affordable Growth Opportunity
9 days ago - By: Chartmill
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Combines Strong Growth with Bullish Technical Setup
6 days ago - By: Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
6 days ago - By: Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
11 days ago - By: Zacks Investment Research
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock
11 days ago - By: Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™
11 days ago - By: Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™
12 days ago - By: Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
12 days ago - By: Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
13 days ago - By: Chartmill
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Stands Out as a Quality Investment on Caviar Cruise Screen
17 days ago - By: Zacks Investment Research
- Mentions:
ZTS
CPRX vs. ZTS: Which Stock Is the Better Value Option?
17 days ago - By: Zacks Investment Research
Wall Street Analysts Believe Catalyst (CPRX) Could Rally 51.45%: Here's is How to Trade
17 days ago - By: Zacks Investment Research
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock
17 days ago - By: Zacks Investment Research
- Mentions:
ABVX
Are Medical Stocks Lagging Abivax SA Sponsored ADR (ABVX) This Year?
17 days ago - By: Zacks Investment Research
Should Value Investors Buy Catalyst Pharmaceuticals (CPRX) Stock?
24 days ago - By: Zacks Investment Research
- Mentions:
FOLD
ANIP
ACAD
Catalyst Pharmaceuticals Q3 Earnings Beat, Firdapse Revenues Rise Y/Y
24 days ago - By: Zacks Investment Research
Compared to Estimates, Catalyst (CPRX) Q3 Earnings: A Look at Key Metrics
24 days ago - By: Zacks Investment Research
- Mentions:
GRDN
Catalyst Pharmaceutical (CPRX) Beats Q3 Earnings and Revenue Estimates
24 days ago - By: Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
24 days ago - By: Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
25 days ago - By: Benzinga
- Mentions:
TECH
INSE
GEF
SKYT
...
Earnings Scheduled For November 5, 2025
25 days ago - By: Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work
25 days ago - By: Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work
a month ago - By: Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference
a month ago - By: Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference
a month ago - By: Zacks Investment Research
- Mentions:
COLL
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: Should You Buy?
a month ago - By: Zacks Investment Research
- Mentions:
ZTS
Earnings Preview: Catalyst Pharmaceutical (CPRX) Q3 Earnings Expected to Decline
a month ago - By: Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025
a month ago - By: Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025
a month ago - By: Benzinga
What Does the Market Think About Catalyst Pharmaceuticals Inc?
2 months ago - By: Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
2 months ago - By: Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
2 months ago - By: Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program
2 months ago - By: Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program
Please enable JavaScript to continue using this application.